The Melanoma and Cutaneous Malignancies Program represents an expansion of the former Melanoma Program which has been funded by the CCSG since 1978. It provides the organizational structure and research forum for the efficient conduct of collaborative basic, clinical, and epidemiologic research in melanoma, BCC and SCC, and cutaneous lymphoma. Lynn Schuchter, M.D. was appointed Program Leader in 2007, having been an active member of this program since 1989. Members have a high degree of collaboration with other Research Programs and extramural investigators, The overall goals of the Melanoma and Cutaneous Malignancies Program are: 1) To understand the genetic, epidemiology, molecular mechanisms, and biology of cutaneous malignancies;2) To translate approaches from the preclinical arena into novel treatment strategies;and 3) To foster and support intra and interprogrammatic and external scientific collaborations to better understand the biology and therapy of cutaneous malignancies. The research Interests and efforts of program members are centered on four highly translational themes and are articulated through several collaborative mechanisms (e.g., monthly research meetings, a yearly retreat sponsored by the Cancer Center) and NCI-funded multi-investigator research grants. Critically important resources have been developed by program members and supported by the Cancer Center which has fostered the highly productive, translational research conducted by program members. This includes a comprehensive melanoma database, a melanoma pathology facility, from which investigators can access annotated pathology slides and blocks (normal skin and lesions) of patients seen as far back as 30 years ago;a Pigmented Lesion Clinic for the conduct of epidemiological studies, and a large biorepository of thousands of collected blood and tumor samples from patients with cutaneous lymphoma. The success of these efforts is reflected in the award ofthe Skin Cancer SPORE and additional grants in laboratory-based translational and population science research, including two NIH/NCI POl grants, a newly awarded GO Challenge grant and grants from The Leukemia and Lymphoma Society to support innovative clinical research in cutaneous lymphoma. In total, the 19 members have $7,600,068 in research funding (annual direct costs) of which $7,102,900 is peer-reviewed and $4,237,420 is from the NCI. The members have published 373 cancer related publications since 2004, of which 20% are intra-programmatic and 36% are inter-programmatic publications.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA016520-38
Application #
8593255
Study Section
Subcommittee G - Education (NCI)
Project Start
Project End
Budget Start
2013-12-01
Budget End
2014-11-30
Support Year
38
Fiscal Year
2014
Total Cost
$97,936
Indirect Cost
$86,401
Name
University of Pennsylvania
Department
Type
DUNS #
042250712
City
Philadelphia
State
PA
Country
United States
Zip Code
19104
Taylor, Laura A; Abraham, Ronnie M; Tahirovic, Emin et al. (2017) High ALDH1 expression correlates with better prognosis in tumorigenic malignant melanoma. Mod Pathol 30:634-639
Rebecca, Vito W; Nicastri, Michael C; McLaughlin, Noel et al. (2017) A Unified Approach to Targeting the Lysosome's Degradative and Growth Signaling Roles. Cancer Discov 7:1266-1283
Till, Jacob E; Yoon, Changhwan; Kim, Bang-Jin et al. (2017) Oncogenic KRAS and p53 Loss Drive Gastric Tumorigenesis in Mice That Can Be Attenuated by E-Cadherin Expression. Cancer Res 77:5349-5359
Ewens, Kathryn G; Bhatti, Tricia R; Moran, Kimberly A et al. (2017) Phosphorylation of pRb: mechanism for RB pathway inactivation in MYCN-amplified retinoblastoma. Cancer Med 6:619-630
Chee, Wonshik; Lee, Yaelim; Im, Eun-Ok et al. (2017) A culturally tailored Internet cancer support group for Asian American breast cancer survivors: A randomized controlled pilot intervention study. J Telemed Telecare 23:618-626
Zang, Tianzhu; Taplin, Mary-Ellen; Tamae, Daniel et al. (2017) Testicular vs adrenal sources of hydroxy-androgens in prostate cancer. Endocr Relat Cancer 24:393-404
Walter, David M; Venancio, Olivia S; Buza, Elizabeth L et al. (2017) Systematic In Vivo Inactivation of Chromatin-Regulating Enzymes Identifies Setd2 as a Potent Tumor Suppressor in Lung Adenocarcinoma. Cancer Res 77:1719-1729
Carrer, Alessandro; Parris, Joshua L D; Trefely, Sophie et al. (2017) Impact of a High-fat Diet on Tissue Acyl-CoA and Histone Acetylation Levels. J Biol Chem 292:3312-3322
Fennelly, Colin; Amaravadi, Ravi K (2017) Lysosomal Biology in Cancer. Methods Mol Biol 1594:293-308
Safo, Sandra E; Li, Shuzhao; Long, Qi (2017) Integrative analysis of transcriptomic and metabolomic data via sparse canonical correlation analysis with incorporation of biological information. Biometrics :

Showing the most recent 10 out of 955 publications